丙型肝炎病毒C+E1区基因在原核细胞中的克隆与表达

将丙型肝炎病毒Ｃ＋Ｅ１区基因插入到原核高效表达载体ｐＢＶ２２１质粒中,构建了质粒ｐＢＶ２２１ＨＣＶ／Ｃ＋Ｅ１作为表达载体,然后,将含有该质粒的宿主大肠杆菌进行升温诱导表达ＨＣＶ／Ｃ＋Ｅ１区基因,并对表达产物进行了生物活性的检测。结果表明,插入到表达载体ｐＢＶ２２１中的ＨＣＶ／Ｃ＋Ｅ１基因片段能够得到有效的表达,表达产物主要为非融合蛋白形式存在于细胞中,同时这种Ｃ区和Ｅ１区连接共表达的产物保持了良好的抗原活性     

Selection of lambda Spi- transducing phages using the P2 old gene cloned onto a plasmid

The old gene product of the P2 prophage interferes with plaque formation by lambda wild type phage but allows lambda phages whose red and gam genes have been deleted to form small, visible plaques (the lambda Spi- phenotype). The old gene product also kills Escherichia coli recB or recC mutants. We have cloned the old gene into the high-copy-number plasmid pBR322, where it prevents plaque formation by both lambda Spi+ and lambda Spi- phages. We transferred a DNA fragment that carries the old gene to the low-copy-number plasmid pSC101 and found that lambda Spi- phages can be selected on strains that carry this plasmid. The plasmid-borne old gene kills E. coli recB mutants, providing a selection for old- mutants.     

Reversion of Q beta RNA phage mutants by homologous RNA recombination.

Q beta phage RNAs with inactivating insertion (8-base) or deletion (17-base) mutations within their replicase genes were prepared from modified Q beta cDNAs and transfected into Escherichia coli spheroplasts containing Q beta replicase provided in trans by a resident plasmid. Replicase-defective (Rep-) Q beta phage produced by these spheroplasts were detected as normal-sized plaques on lawns of cells containing plasmid-derived Q beta replicase, but were unable to form plaques on cells lacking this plasmid. When individual Rep- phage were isolated and grown to high titer in cells containing plasmid-derived Q beta replicase, revertant (Rep+) Q beta phage were obtained at a frequency of ca. 10(-8). To investigate the mechanism of this reversion, a point mutation was placed into the plasmid-derived Q beta replicase gene by site-directed mutagenesis. Q beta mutants amplified on cells containing the resultant plasmid also yielded Rep+ revertants. Genomic RNA was isolated from several of the latter phage revertants and sequenced. Results showed that the original mutation (insertion or deletion) was no longer present in the phage revertants but that the marker mutation placed into the plasmid was now present in the genomic RNAs, indicating that recombination was one mechanism involved in the reversion of the Q beta mutants. Further experiments demonstrated that the 3' noncoding region of the plasmid-derived replicase gene was necessary for the reversion-recombination of the deletion mutant, whereas this region was not required for reversion or recombination of the insertion mutant. Results are discussed in terms of a template-switching model of RNA recombination involving Q beta replicase, the mutant phage genome, and plasmid-derived replicase mRNA.     

含口蹄疫病毒IRES RNA病毒样颗粒表达载体的构建

利用PCR技术扩增大肠杆菌MS2噬菌体的外壳蛋白和成熟酶蛋白基因,将其克隆到pET32a中构建中间载体pET32a-CP。将FMDV的内部核糖体结合位点（IRES）保守序列连接到中间载体噬菌体基因的下游,构建原核表达载体pCPES。将重组质粒pCPES转化宿主菌BL21(DE3),1 mmol/L IPTG诱导表达。蔗糖密度梯度离心纯化表达产物。透射电镜观察到直径大约26 nm的圆形病毒样颗粒。检测病毒样颗粒的稳定性并进行RT-PCR鉴定。结果表明该病毒样颗粒含口蹄疫病毒IRES RNA序列,并且稳定性良好,本研究构建的病毒样颗粒可以作为RNA病毒检测时的标准品和质控品使用。     

细菌表达dsRNA介导的家蚕FTZ-F1基因的RNA干扰

为探索细菌表达目标基因dsRNA介导的RNAi技术是否在家蚕Bombyx mori可行, 本研究引入了在其他物种中广泛应用的细菌表达dsRNA的RNAi系统: HT115细菌株和L4440质粒。利用L4440载体两端含有T7启动子的特点, 设计并构建了针对家蚕核受体FTZ-F1基因的RNA干扰（RNA interference）载体, 将构建好的质粒转入大肠杆菌Escherichia coli HT115, 在IPTG诱导下成功获得目标基因对应双链RNA（dsRNA）。 结果显示: 通过对5龄第7天家蚕幼虫注射IPTG诱导后提取的FTZ F1基因对应的dsRNA 25 μg, 85%的蛹变态发育过程明显延迟, 不能实现幼虫到蛹的形态完全转变。荧光定量PCR分析显示目标基因的表达得到了特异的抑制。实验结果初步表明, 通过细菌表达目标基因dsRNA介导的RNAi策略, 以其经济、高效的特点, 具有广泛应用于家蚕基因功能研究中的潜力。     

米曲霉(Aspergillus oryzae)果胶酸内切水解酶(PGA)在原核系统中重组表达

果胶酶具有广阔的商业用途,在食品工业上主要用于果汁和酒类的澄清、提高植物油的提取率、提高水果的硬度和植物纤维脱胶。米曲霉(Aspergillusoryzae)一直用于传统发酵食品的生产,自然条件下其果胶酶的产量较低。文献报道的果胶酶的重组表达成功的例子较少,且活性较低。通过RT-PCR的方法,获得不含信号肽的果胶酸内切水解酶A(polygalacturonaseA,PGA)的cDNA,PGAcDNA连入pET-28a( )载体,构建pET-28a( )-pga质粒。pET-28a( )-pga转化Turner(DE3)placⅠ细胞,得到转化子pET-28a( )-pga-Turner(DE3)placⅠ,首次实现了米曲霉PGA在大肠杆菌系统中过表达,进一步对PGA在大肠杆菌系统中表达的条件进行了研究。在37℃、220r/min条件培养pET-28a( )-pga-Turner(DE3)placⅠ细胞,OD600至0·8左右时,用500μmol/Lisopropylβ-D-thiogalactogalactopyranoside(IPTG)进行诱导表达,在15℃和170r/min条件下继续培养24h,表达效果最好,相对于每毫升培养基而言,产酶可达到70u/mL,是米曲霉自然条件产酶量的87·5倍,远优于文献报道的重组表达的PGA酶活。     

Replication of lambda plasmid in amino acid-starved strains of Escherichia coli.

We found that lambda plasmid replication, as measured by the increase in plasmid content per bacterial mass, proceeds for hours in an amino acid-starved, relaxed mutant of Escherichia coli K-12, whereas is inhibited in its wild-type stringent partner. Replication of lambda plasmid in amino acid-starved, relaxed cells reveals absolute lambda O dependence and is not inhibited by chloramphenicol at 200 micrograms/ml. The replication also occurs in wild-type cells treated with chloramphenicol. We conclude that lambda plasmid replication is under stringent control, probably as a result of the action of ppGpp, the signal for the stringent response, on RNA polymerase.     

小鼠精胺氧化酶的原核表达与鉴定

目的:原核表达和分离纯化小鼠精胺氧化酶(SMO)。方法:采用RT-PCR法从小鼠胚胎干细胞(ES细胞)RNA中克隆小鼠SMOcDNA,构建SMO原核表达质粒并转染大肠杆菌BL21(DE3)菌株,经IPTG诱导,将表达的小鼠SMO重组蛋白在变性条件下经Ni-NTA树脂亲和层析纯化和透析复性。结果:在大肠杆菌中高表达出小鼠SMO重组蛋白;纯化并透析复性后的重组SMO具备快速氧化特异性底物精胺的酶活性。结论:建立了原核表达和纯化有活性小鼠SMO的实验方法。     

神经粘附分子NCAM140 基因RNA干扰质粒的构建与鉴定

摘要目的：构建有效的小鼠神经粘附分子（NCAM140）基因的RNA 干扰（RNAi）质粒载体,为研究NCAM140参与的细胞信号通 路转导、其生物学作用以及以NCAM140 为靶点的基因治疗提供稳定转染的RNAi 质粒。方法：使用基因序列软件设计、筛选符 合公开文献筛选参数的4 条靶序列以及1条阴性对照序列,由上海吉玛技术有限公司合成。与载体质粒pGPU6/GFP/Neo 重组后, 分别命名为pSi-nca1、pSi-nca2、pSi-nca3、pSi-nca4和pSi-control。转染大肠杆菌感受态细胞。选择阳性克隆进行DNA 测序鉴定, Western blot方法进行干扰靶点的筛选。选取干扰效率最高的质粒转染MN9D 细胞,普通光学显微镜分别计数同一视野细胞总数 及GFP阳性细胞数,计算转染效率。结果：酶切和DNA 测序结果证实shRNA正确插入pGPU6/GFP/Neo 质粒;Western blot结果 显示与空质粒对照组比较,pSi-nca4 组细胞NCAM140 表达明显下调,细胞转染效率为62 %。结论：成功构建靶向小鼠 NCAM140 基因的RNAi 质粒,为NCAM140 参与的细胞信号通路的研究以及以NCAM140为靶点的基因治疗提供了稳定转染 细胞的干扰质粒,为研究其生物学作用奠定了分子生物学基础。     

The nucleotide and deduced amino acid sequences of EcoRI fragment containing the 5'-terminal region of Clostridium botulinum type E toxin gene cloned from Mashike, Iwanai and Otaru strains

Chromosomal DNAs were extracted from toxigenic three Clostridium botulinum type E strains isolated from food-borne botulism. After digestion by EcoRI, the fragments were cloned into Escherichia coli by using bacteriophage lambda gt11 and screened with monoclonal antibody recognizing the light chain component of botulinum type E toxin. The fragments (about 1 kbp size) cloned from each strain were recloned into a plasmid vector pUC118. The E. coli cells transformed with the recombinant plasmids produced 33 kDa protein with or without IPTG (isopropyl-beta-D-thiogalactopyranoside) which reacted with the monoclonal antibody. The nucleotide sequences of the cloned EcoRI fragments from the three type E strains were identical and contain the 5'-terminal region of the type E toxin gene. It was also found that there exist several highly homologous nucleotide sequences among the botulinum types A, C and E, and tetanus toxin genes in both translated and untranslated regions.     

The role of the OOP antisense RNA in coliphage λ development

We have made a derivative of bacteriophage lambda that makes no OOP antisense RNA. The mutant phage carries a point mutation that inactivates the OOP promoter, po. The phages lambda + and lambda po- have identical plaque morphologies, one-step growth curves, and frequencies of lysogenization of a sensitive host. OOP RNA synthesis is weakly repressed by the Escherichia coli LexA protein. Consonant with this inducibility of OOP RNA synthesis by ultraviolet light, we find a two-fold greater phage burst following ultraviolet induction of a lambda + than of a lambda po- prophage. In lambda + infections, OOP RNA causes two cleavage events in cll mRNA: one is in the 3'-end of the coding region, and the second is in the intercistronic region between the cll and O genes. The cll gene fragments are subject to additional hydrolytic events, and cll mRNA levels are several-fold lower in lambda + than in lambda po- infections late in the infection cycle. However, O mRNA levels are almost unaffected by the po- mutation.     

人抗酶抑制因子-1的克隆与原核表达

目的:克隆人抗酶抑制因子-1(ornithine decarboxylase antizyme inhibitor-1,OAZI-1)cDNA,建立在大肠杆菌中原核表达并纯化人OAZI-1蛋白的实验技术。方法:巢式RT-PCR法从人A549总RNA中扩增人OAZI-1 cDNA并构建pET-28a/OAZI-1原核表达质粒。该质粒转化大肠杆菌原核表达菌BL21(DE3)后IPTG诱导表达。诱导表达出的重组蛋白用Ni-NTA树脂亲和层析纯化。SDS-PAGE和Western法检测重组OAZI-1蛋白的表达和纯化。结果:成功克隆出编码全长人OAZI-1的cDNA序列,并构建出原核表达质粒pET-28a/OAZI-1。DNA测序分析,重组质粒中的OAZI-1 cDNA无突变,与6×His标签框架对接正确。重组质粒转化入大肠杆菌表达菌BL21(DE3)中后,可用IPTG诱导表达出重组OAZI-1蛋白,该重组蛋白可用Ni-NTA树脂亲和层析纯化。结论:成功建立了人抗酶抑制因子的原核表达和纯化的实验方法,为后续OAZI-1的功能研究奠定了基础。     

Pseudomonas putida S1海藻糖合成酶表达质粒的构建及诱导条件优化

采用PCR方法从Pseudomonas putida S1中克隆出编码海藻糖合成酶的基因treS,并与质粒pQE30T相连,构建了表达质粒pQE—TS2。将此重组质粒转化宿主菌E．coliM15进行诱导表达。十二烷基磺酸钠-聚丙烯酰胺凝胶SDS—PAGE电泳结果表明,treS基因在大肠杆菌中获得了高效表达。通过对诱导温度、诱导剂浓度、加诱导剂时间和诱导时间的优化研究,在菌液生长至OD600值为0．6时,加入诱导剂IPTG至终浓度0．01mmol／L,20℃诱导20h,蛋白的表达量达到每克干细胞89mg的蛋白,粗酶液酶活达到19U／mL。     

人TIMP—3cDNA的克隆,表达及其抗血管生成作用

从人新鲜的胎盘组织中提取总ＲＮＡ,以ＲＴ－ＰＣＲ法获取了人组织金属蛋白酶抑制－３成熟蛋白的ｃＤＮＡ。序列分析表明,ＴＩＭＰ－３成熟蛋白含有１８８个氨基酸残基,其中１２个半胱氨酸残基在ＴＩＭＰ家族中高度保守。将人ＴＩＭＰ－３ｃＤＮＡ插入含７启动子的质粒ｐＥＴ－２４构建表达质粒ｐＥＴ－ＴＩＭＰ３,转化大肠杆菌ＢＬ２１,筛选表达菌株ＢＬＴＩＭＰ３。     

人GM—CSF cDNA的克隆和在大肠杆菌中的表达

从诱导的人胚肺细胞ＨＦＬ株中提取总ＲＮＡ．经ＲＴ－ＰＣＲ反应获取了人ＧＭ－ＣＳＦｃＤＮＡ,ＤＮＡ序列测定表明其顺序与文献报道完全一致。为了获得高效表达,应用ＰＣＲ改造了人ＧＭ－ＣＳＦ的ｃＤＮＡ５’端核苷酸序列,并将改造的人ＧＭ－ＣＳＦ基因插入含Ｔ７启动子的质粒ｐＥＴ－１１ｄ构建成表达质粒ｐＥＴＣ－５,将此质粒转化大肠杆菌株ＢＬ２１（ＤＥ３）得到表达菌株ＢＬＥＣ４。表达菌株用０．５ｍｏｌ／ＬＩＰＴＧ诱导２小时后,产生大量重组蛋白并形成包涵体。ＳＤＳ—ＰＡＧＥ电泳图谱扫描结果表明,ｒｈＧＭ－ＣＳＦ产量占菌体总蛋白量的１６％。ＥＬＩＳＡ和ＴＦ－１细胞培养测定表明,初步纯化和复性的ｒｈＧＭ－ＣＳＦ具有天然的ｈＧＭ－ＣＳＦ生物活性。